Literature DB >> 26759742

Talc seromadesis in patients with chronic seroma formation after breast surgery.

Coriene J L M Catsman1, Martinus A Beek1, Arjen M Rijken1.   

Abstract

BACKGROUND: Seroma formation, after breast surgery is a commonly seen complication with an incidence ranging from 10 to 85 %. In general, though seroma usually disappears within several weeks, some patients are troubled with chronic seroma. Seroma predisposes to infection leading to wound related complications and may also delay adjuvant chemoradiation, leading to less effective breast cancer treatment. CASE DESCRIPTION: A 52-years-old Dutch woman presenting with a pT3N1M0 infiltrating lobular breast carcinoma received neo-adjuvant chemotherapy, following modified radical mastectomy with sentinel node procedure. She suffered from chronic seroma formation, delaying adjuvant radiation therapy. We successfully performed talc seromadesis to eliminate seroma formation. During six-month follow-up, no seroma was detected. DISCUSSION AND EVALUATION: Talc seromadesis after breast surgery is a rarely described in literature. In order to develop this technique further research aimed to evaluate its effectiveness on safety and possible later breast reconstruction must be carried out.
CONCLUSION: Talc seromadesis may be a safe, cost effective and minimally invasive solution to treat chronic seroma after breast surgery.

Entities:  

Keywords:  Breast cancer; Chronic seroma formation; Talc seromadesis

Year:  2016        PMID: 26759742      PMCID: PMC4700035          DOI: 10.1186/s40064-015-1648-5

Source DB:  PubMed          Journal:  Springerplus        ISSN: 2193-1801


Background

Seroma formation after breast surgery is a commonly seen complication with an incidence ranging from of 10 to 85 %. The incidence of seroma formation has been shown to correlate with age, hypertension and breast size, and it may be operator and technique dependent (Kuroi et al. 2005). In general, though seroma usually disappears within several weeks, some patients are troubled with chronic seroma requiring continued seroma aspiration. It is assumed that seroma formation is caused by insufficient lymph drainage. Seroma predisposes to infection leading to wound related complications and may also delay adjuvant chemoradiation, leading to less effective breast cancer treatment (McCaul et al. 2000). Seroma formation is a commonly seen complication following breast surgery in our surgical center. In this case report we describe a patient with chronic seroma formation after breast surgery who is successfully treated with talc seromadesis.

Case description

A 52-years-old Dutch woman presenting with a pT3N1M0 infiltrating lobular breast carcinoma received neo-adjuvant chemotherapy, following modified radical mastectomy with sentinel node procedure. She suffered from chronic seroma formation. During initial surgery two drains were placed in both the mammary region and the axillary region. The drain positioned in the mammary region was removed 3 days after surgery because of minor liquid collection. The drain positioned in the axillary region was removed 12 days after surgery because of production of less than 30 mL a day. Seroma was first detected 14 days after surgery, being aspirated at day 24 after surgery. During a period of two and a half months seroma was aspirated nine times. Because of recurrent seroma formation adjuvant radiation therapy was delayed. In order to continue breast cancer treatment, we tried to find an effective solution to eliminate seroma formation. Currently, there is no evidence based standardized procedure for treating chronic seroma. Several techniques to solve chronic seroma formation such as surgical closure of the dead space between skin and thorax wall (O’Dwyer et al. 1991), talc seromadesis of the seroma cavity (Saeb-Parsy et al. 2006), tetracycline sclerotherapy (Taghizadeh et al. 2008) and wound closure with a quilting technique (Sajid et al. 2011). In consultation with the patient and our breast surgery team we decided to perform talc seromadesis because this procedure is described as an effective solution to treat seroma formation (Saeb-Parsy et al. 2006).

Technique description

Under full anesthesia, a 5 cm long lateral incision was made in the line of the previous operation wound. Sterilized dry talc powder was insufflated into the wound (Figs. 1 and 2). A drain was positioned and a compression bandage was assembled.
Fig. 1

Talc insuflatting device

Fig. 2

Talc insuflattion into operation wound

Talc insuflatting device Talc insuflattion into operation wound

Result

The compression bandage and drain were removed 1 week after the procedure and collected a total of 145 mL. Both the procedure and recovery of the patient were without complications. Three weeks after talc seromadesis, the patient was fully recovered (Fig. 3). During 6 month follow-up, no seroma recurred. The patient was able to continue with adjuvant chemoradiation.
Fig. 3

Result one-month after talc seromadesis

Result one-month after talc seromadesis

Discussion and evaluation

Talc seromadesis is inspired by pleurodesis and is a widely accepted technique to treat pleural effusion and recurrent pneumothorax. In talc seromadesis, talc is used as a sclerotic agent which induces a fibrotic reaction, causing adhesion between skin and thoracic wall (Saeb-Parsy et al. 2006, Rodriguez-Panadero and Antony 1997). Talc seromadesis after breast surgery is a poorly described subject in literature. It appears to be a safe, cost-effective and minimal invasive method solution to treat chronic seroma formation after breast surgery. In order to develop this technique further research aimed to evaluate its effectiveness on safety and possible later breast reconstruction must be carried out.

Conclusion

Talc seromadesis may be a safe, cost effective and minimally invasive solution to treat chronic seroma formation after breast surgery.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
  7 in total

1.  Talc seromadesis: a novel technique for the treatment of chronic seromas following breast surgery.

Authors:  Kourosh Saeb-Parsy; Vassilis Athanassoglou; John R Benson
Journal:  Breast J       Date:  2006 Sep-Oct       Impact factor: 2.431

Review 2.  Prevention of postoperative seroma-related morbidity by quilting of latissimus dorsi flap donor site: a systematic review.

Authors:  M S Sajid; D Betal; N Akhter; I F Rapisarda; R Bonomi
Journal:  Clin Breast Cancer       Date:  2011-06-25       Impact factor: 3.225

Review 3.  Pleurodesis: state of the art.

Authors:  F Rodriguez-Panadero; V B Antony
Journal:  Eur Respir J       Date:  1997-07       Impact factor: 16.671

Review 4.  Pathophysiology of seroma in breast cancer.

Authors:  Katsumasa Kuroi; Kojiro Shimozuma; Tetsuya Taguchi; Hirohisa Imai; Hiroyasu Yamashiro; Shozo Ohsumi; Shinya Saito
Journal:  Breast Cancer       Date:  2005       Impact factor: 4.239

5.  Triamcinolone reduces seroma re-accumulation in the extended latissimus dorsi donor site.

Authors:  Rieka Taghizadeh; Taimur Shoaib; Andrew M Hart; Eva M Weiler-Mithoff
Journal:  J Plast Reconstr Aesthet Surg       Date:  2007-05-11       Impact factor: 2.740

6.  Aetiology of seroma formation in patients undergoing surgery for breast cancer.

Authors:  J A McCaul; A Aslaam; R J Spooner; I Louden; T Cavanagh; A D Purushotham
Journal:  Breast       Date:  2000-06       Impact factor: 4.380

7.  Effect of closing dead space on incidence of seroma after mastectomy.

Authors:  P J O'Dwyer; N J O'Higgins; A G James
Journal:  Surg Gynecol Obstet       Date:  1991-01
  7 in total
  2 in total

1.  Complete axillary dissection without drainage for the surgical treatment of breast cancer: a randomized clinical trial.

Authors:  Ruffo Freitas-Junior; Luís Fernando Jubé Ribeiro; Marise Amaral Rebouças Moreira; Geraldo Silva Queiroz; Maurício Duarte Esperidião; Marco Aurélio Costa Silva; Rubens José Pereira; Rossana Araújo Catão Zampronha; Rosemar Macedo Sousa Rahal; Leonardo Ribeiro Soares; Danielle Laperche Dos Santos; Maria Virginia Thomazini; Cassiana Ferreira Silva de Faria; Régis Resende Paulinelli
Journal:  Clinics (Sao Paulo)       Date:  2017-07       Impact factor: 2.365

2.  Sclerotherapy for the Management of Seromas: A Systematic Review.

Authors:  Aditya Sood; Vasanth S Kotamarti; Paul J Therattil; Edward S Lee
Journal:  Eplasty       Date:  2017-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.